Drug: ATARAX Injury: Hepatocellular injury Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 120130184 | ATARAX | Hepatocellular injury | ASTRAZENECA | 343.00 MON | F | 86 KG | 20160713 | FR |
| 120610102 | ATARAX | Hepatocellular injury | TEVA | 28.57 YR | F | 86 KG | 20160714 | FR |
| 120774643 | ATARAX | Hepatocellular injury | JOHNSON AND JOHNSON | 28.73 YR | F | 86 KG | 20160719 | FR |
| 120795683 | ATARAX | Hepatocellular injury | PFIZER | 28.00 YR | F | 86 KG | 20160719 | FR |
| 125270511 | ATARAX | Hepatocellular injury | GLAXOSMITHKLINE | 28.73 YR | F | 0 | 20160705 | FR |
| 125413341 | ATARAX | Hepatocellular injury | UCB | 28.73 YR | F | 86 KG | 20160708 | FR |
| 125508542 | ATARAX | Hepatocellular injury | TEVA | 28.73 YR | F | 0 | 20160715 | FR |
| 125656731 | ATARAX | Hepatocellular injury | PFIZER | 28.00 YR | F | 0 | 20160718 | FR |
Total Records: 8 Number of Pages: 1